[1]
M. P. M. Galeazzi et al., “Pd-1 inhibitors immune-mediated side effects”, Rev Hosp Ital B.Aires, vol. 39, no. 4, pp. 146–148, Dec. 2019, doi: 10.51987/Rev.Hosp.Ital.B.Aires.v39i4.504.